Nifty

:

15934.65

Sensex

:

53241.87

-305.65 (-1.88%)
-966.66 (-1.78%)

Login

Nifty
Sensex

:
:

15934.65
53241.87

-305.65 (-1.88%)
-966.66 (-1.78%)

Sun Pharma Advanced Research Company Ltd.

Pharmaceuticals & Drugs - Global

Rating :

48/99

BSE: 532872 | NSE: SPARC

Watchlist

NSE BSE

228.70

18-May-2022

Open
High
Low
Previous Close

232.15
235.00
226.45
231.75

Volume
Traded Value (lacs)
52 Week High
52 Week Low

272459
624.72
349.00
201.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

6,215.15
N/A
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

6,440.60
N/A
199.02

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

24.19
6.92
11.42

EBITDA CAGR (%)

10 Years
5 Years
3 Years

6.80
1.92
-2.26

PAT CAGR (%)

10 Years
5 Years
3 Years

7.66
4.89
1.29

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-36.33
-36.33
-36.33

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-17.52
-35.18
-28.97

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 22 Mar 21 Var% Dec 21 Dec 20 Var% Sep 21 Sep 20 Var% Jun 21 Jun 20 Var%
Net Sales 25.24 28.06 -10.05% 62.15 21.81 184.96% 27.87 17.64 57.99% 21.99 185.45 -88.14%
Expenses 91.78 78.49 16.93% 73.42 84.77 -13.39% 83.04 100.01 -16.97% 76.26 124.67 -38.83%
EBITDA -66.54 -50.43 - -11.27 -62.96 - -55.17 -82.37 - -54.27 60.78 -
EBIDTM -263.63% -179.72% -18.13% -288.67% -197.95% -466.95% -246.79% 32.77%
Other Income 0.22 0.33 -33.33% 0.34 1.60 -78.75% 5.98 2.82 112.06% 0.80 0.66 21.21%
Interest 2.22 4.02 -44.78% 2.33 3.50 -33.43% 3.41 1.16 193.97% 5.37 1.97 172.59%
Depreciation 2.51 2.60 -3.46% 2.58 2.76 -6.52% 2.54 2.78 -8.63% 2.53 2.78 -8.99%
PBT -71.05 -56.72 - -15.84 -67.62 - -55.14 -83.49 - -61.37 56.69 -
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT -71.05 -56.72 - -15.84 -67.62 - -55.14 -83.49 - -61.37 56.69 -
PATM -281.50% -202.14% -25.49% -310.04% -197.85% -473.30% -279.08% 30.57%
EPS -2.61 -2.09 - -0.58 -2.49 - -2.03 -3.07 - -2.26 2.08 -

Description Dec 21 Dec 20 Var% Sep 21 Sep 20 Var% Jun 21 Jun 20 Var% Mar 21 Mar 20 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Net Sales 137.25 252.96 76.81 182.87 78.26 181.02 161.28 155.74 167.03 87.28 28.98 Net Sales Growth -45.74% 229.33% -58.00% 133.67% -56.77% 12.24% 3.56% -6.76% 91.37% 201.17% Cost Of Goods Sold 18.27 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Gross Profit 118.98 252.96 76.81 182.87 78.26 181.02 161.28 155.74 167.03 87.28 28.98 GP Margin 86.69% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% Total Expenditure 324.50 387.93 386.83 334.16 320.87 303.72 224.48 190.83 133.54 104.04 98.92 Power & Fuel Cost - 4.60 5.14 5.08 4.92 4.67 4.49 4.78 3.95 3.85 3.35 % Of Sales - 1.82% 6.69% 2.78% 6.29% 2.58% 2.78% 3.07% 2.36% 4.41% 11.56% Employee Cost - 91.59 93.09 81.06 100.92 84.30 56.60 45.79 40.40 36.55 30.43 % Of Sales - 36.21% 121.20% 44.33% 128.95% 46.57% 35.09% 29.40% 24.19% 41.88% 105.00% Manufacturing Exp. - 25.76 30.47 17.81 31.79 29.39 26.42 17.96 16.19 15.84 12.99 % Of Sales - 10.18% 39.67% 9.74% 40.62% 16.24% 16.38% 11.53% 9.69% 18.15% 44.82% General & Admin Exp. - 262.51 251.32 221.40 181.18 180.29 131.88 119.37 71.71 46.26 51.31 % Of Sales - 103.78% 327.20% 121.07% 231.51% 99.60% 81.77% 76.65% 42.93% 53.00% 177.05% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 3.48 6.81 8.80 2.05 5.06 5.08 2.94 1.29 1.54 0.00 % Of Sales - 1.38% 8.87% 4.81% 2.62% 2.80% 3.15% 1.89% 0.77% 1.76% 2.93% EBITDA -187.25 -134.97 -310.02 -151.29 -242.61 -122.70 -63.20 -35.09 33.49 -16.76 -69.94 EBITDA Margin -136.43% -53.36% -403.62% -82.73% -310.01% -67.78% -39.19% -22.53% 20.05% -19.20% -241.34% Other Income 7.34 5.41 9.76 13.51 4.94 13.72 2.94 3.03 10.00 1.62 1.15 Interest 13.33 10.65 2.67 0.09 0.12 1.82 2.16 0.22 5.60 3.95 0.27 Depreciation 10.16 10.92 9.48 7.55 8.18 8.24 7.58 7.24 3.57 3.40 3.16 PBT -203.40 -151.14 -312.40 -145.43 -245.97 -119.04 -69.99 -39.52 34.32 -22.49 -72.23 Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.00 0.00 0.00 Tax Rate 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 11.66% 0.00% 0.00% PAT -203.40 -151.14 -312.40 -145.43 -197.00 -119.04 -69.99 -39.52 30.32 -22.49 -72.23 PAT before Minority Interest -203.40 -151.14 -312.40 -145.43 -197.00 -119.04 -69.99 -39.52 30.32 -22.49 -72.23 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -148.20% -59.75% -406.72% -79.53% -251.73% -65.76% -43.40% -25.38% 18.15% -25.77% -249.24% PAT Growth 0.00% - - - - - - - - - EPS -7.48 -5.56 -11.49 -5.35 -7.25 -4.38 -2.57 -1.45 1.12 -0.83 -2.66

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Shareholder's Funds -168.25 -18.64 296.24 184.72 158.16 31.80 99.80 139.30 108.43 -66.61 Share Capital 26.21 26.21 26.21 25.09 24.69 23.67 23.67 23.67 23.66 20.71 Total Reserves -194.46 -44.84 270.03 67.96 133.47 6.23 76.13 115.63 84.77 -87.32 Non-Current Liabilities 164.59 55.85 7.20 11.98 10.36 10.02 9.72 9.45 6.32 7.23 Secured Loans 112.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 4.22 6.38 1.09 1.64 2.18 2.73 3.27 3.82 4.36 5.74 Long Term Provisions 8.63 10.23 6.11 10.34 8.18 7.30 6.37 5.48 1.73 1.24 Current Liabilities 233.35 235.36 95.04 116.11 108.03 124.84 37.15 38.79 94.24 145.03 Trade Payables 99.06 158.84 82.92 102.48 94.45 58.15 27.01 29.75 12.79 16.23 Other Current Liabilities 48.54 11.20 7.66 9.42 9.81 12.09 8.98 7.58 3.79 66.06 Short Term Borrowings 80.00 60.00 0.00 0.10 0.41 52.48 0.40 0.82 75.97 61.94 Short Term Provisions 5.75 5.31 4.46 4.10 3.35 2.12 0.77 0.64 1.69 0.79 Total Liabilities 229.69 272.57 398.48 312.81 276.55 166.66 146.67 187.54 208.99 85.65 Net Block 90.56 103.86 57.56 51.74 69.16 69.96 66.79 64.49 65.55 63.93 Gross Block 122.51 135.50 80.22 67.17 77.28 106.82 96.38 86.98 84.57 79.58 Accumulated Depreciation 31.95 31.64 22.66 15.44 8.12 36.86 29.58 22.49 19.02 15.65 Non Current Assets 166.58 205.38 141.09 137.59 118.27 98.88 83.46 76.87 69.14 66.97 Capital Work in Progress 5.23 32.07 24.13 3.27 1.47 0.87 0.02 0.76 0.16 1.14 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 70.64 69.24 59.29 82.48 47.45 27.99 16.55 11.50 3.30 1.69 Other Non Current Assets 0.15 0.20 0.12 0.10 0.19 0.07 0.09 0.11 0.13 0.21 Current Assets 63.11 67.19 257.38 175.22 158.28 66.59 62.93 110.12 139.01 18.24 Current Investments 6.43 8.49 210.58 107.57 9.65 0.00 0.00 6.50 96.91 0.00 Inventories 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Sundry Debtors 17.58 16.05 10.17 17.56 38.90 9.16 19.89 28.00 25.06 4.26 Cash & Bank 9.31 0.46 0.68 1.32 70.31 12.75 17.34 6.56 6.72 6.50 Other Current Assets 29.80 2.86 2.57 2.04 39.43 44.69 25.70 69.06 10.33 7.48 Short Term Loans & Adv. 21.70 39.33 33.39 46.73 37.48 43.35 24.27 63.34 9.69 7.15 Net Current Assets -170.24 -168.17 162.34 59.11 50.25 -58.24 25.79 71.33 44.77 -126.79 Total Assets 229.69 272.57 398.47 312.81 276.55 166.65 146.67 187.55 208.99 85.64

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Cash From Operating Activity -151.90 -210.81 -171.91 -182.77 -128.04 -44.21 -41.17 36.90 -95.34 -69.45 PBT -151.14 -312.40 -145.43 -245.97 -119.04 -69.99 -39.52 34.32 -22.49 -72.23 Adjustment 49.64 9.44 -21.77 3.82 -1.14 9.25 4.73 0.90 5.71 2.87 Changes in Working Capital -47.88 102.02 -0.17 20.48 12.86 30.41 -3.74 9.80 -77.91 0.70 Cash after chg. in Working capital -149.37 -200.95 -167.38 -221.68 -107.32 -30.34 -38.53 45.03 -94.69 -68.66 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -2.52 -9.86 -4.54 -10.08 -20.72 -13.87 -2.64 -8.13 -0.65 -0.79 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 48.98 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 1.56 155.35 -102.19 -104.62 -6.61 -13.08 53.00 43.59 -99.31 -2.42 Net Fixed Assets 39.83 -63.22 -33.91 8.31 28.94 -11.29 -8.66 -3.01 -4.01 -4.01 Net Investments 2.06 202.09 -103.01 -97.92 -9.65 0.00 6.50 90.41 -96.91 2.47 Others -40.33 16.48 34.73 -15.01 -25.90 -1.79 55.16 -43.81 1.61 -0.88 Cash from Financing Activity 159.28 55.46 274.25 224.01 194.25 50.55 -1.26 -80.84 194.38 72.10 Net Cash Inflow / Outflow 8.95 0.00 0.15 -63.38 59.60 -6.74 10.57 -0.35 -0.27 0.23 Opening Cash & Equivalents 0.35 0.35 0.20 63.58 4.00 10.63 0.01 0.33 0.57 0.34 Closing Cash & Equivalent 9.30 0.35 0.35 0.20 63.58 4.00 10.63 0.01 0.33 0.57

Financial Ratios

Standalone

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Book Value (Rs.) -6.42 -0.71 11.30 3.71 6.41 1.21 4.18 5.82 4.52 -3.16 ROA -60.18% -93.11% -40.89% -66.85% -53.72% -44.68% -23.65% 15.29% -15.27% -88.40% ROE 0.00% -225.08% -74.72% -156.84% -127.40% -109.16% -33.17% 24.62% -110.94% 0.00% ROCE -244.77% -178.95% -59.95% -113.05% -94.66% -71.37% -31.74% 24.02% -19.55% -1066.48% Fixed Asset Turnover 1.96 0.71 2.48 1.08 1.97 1.59 1.70 1.95 1.06 0.37 Receivable days 24.26 62.28 27.67 131.66 48.45 32.87 56.11 57.97 61.31 43.42 Inventory Days 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Payable days 0.00 316.55 300.15 244.72 218.01 163.03 136.14 120.80 88.65 96.96 Cash Conversion Cycle 24.26 -254.27 -272.48 -113.05 -169.56 -130.16 -80.03 -62.83 -27.34 -53.54 Total Debt/Equity -1.40 -3.59 0.01 0.02 0.02 1.94 0.04 0.04 0.75 -1.02 Interest Cover -13.19 -115.79 -1547.78 -1596.71 -64.41 -31.45 -180.04 7.13 -4.69 -261.76

Top Investors:

sun pharmaceutical industries key employees benefit trust

lakshdeep investments & finance (p) ltd.

Annual Reports:

News Update:

No Latest News!

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback